OBJECTIVE: Matrix gla protein (MGP) inhibits arterial and cartilaginous calcification. A threonine to alanine (Thr83Ala) polymorphism (codon 83) in MGP is associated with myocardial infarction and femoral artery calcification. We examined the association of the MGP Thr83Ala polymorphism with quantity and progression of coronary artery calcification (CAC), a noninvasive measure of subclinical coronary atherosclerosis. METHODS AND RESULTS: In 605 participants of the Epidemiology of Coronary Artery Calcification Study, generalized linear mixed models were fit to determine the association of MGP Thr83Ala with CAC quantity and progression. There was a significant additive relation between MGP Thr83Ala and CAC progression (P=0.001). In the fully adjusted model, every 1 Ala83 allele increase was associated with an estimated 1.9% (95% confidence interval, 0.7%-3.0%) per year since baseline larger increase in CAC quantity. A proxy single nucleotide polymorphism for MGP Thr83Ala (rs6488724) was similarly associated with CAC progression in an independent cohort from the Genetic Epidemiology Network of Arteriopathy (GENOA) study. CONCLUSIONS: Increased risk of myocardial infarction associated with MGP ThrAla83 genotype observed elsewhere may be related to faster progression of subclinical coronary atherosclerosis. MGP genotype could be a potential candidate for identifying individuals at increased risk of atherosclerotic disease who would benefit from aggressive primary prevention strategies.
OBJECTIVE:Matrix gla protein (MGP) inhibits arterial and cartilaginous calcification. A threonine to alanine (Thr83Ala) polymorphism (codon 83) in MGP is associated with myocardial infarction and femoral artery calcification. We examined the association of the MGP Thr83Ala polymorphism with quantity and progression of coronary artery calcification (CAC), a noninvasive measure of subclinical coronary atherosclerosis. METHODS AND RESULTS: In 605 participants of the Epidemiology of Coronary Artery Calcification Study, generalized linear mixed models were fit to determine the association of MGP Thr83Ala with CAC quantity and progression. There was a significant additive relation between MGP Thr83Ala and CAC progression (P=0.001). In the fully adjusted model, every 1 Ala83 allele increase was associated with an estimated 1.9% (95% confidence interval, 0.7%-3.0%) per year since baseline larger increase in CAC quantity. A proxy single nucleotide polymorphism for MGP Thr83Ala (rs6488724) was similarly associated with CAC progression in an independent cohort from the Genetic Epidemiology Network of Arteriopathy (GENOA) study. CONCLUSIONS: Increased risk of myocardial infarction associated with MGPThrAla83 genotype observed elsewhere may be related to faster progression of subclinical coronary atherosclerosis. MGP genotype could be a potential candidate for identifying individuals at increased risk of atherosclerotic disease who would benefit from aggressive primary prevention strategies.
Authors: A Farzaneh-Far; J D Davies; L A Braam; H M Spronk; D Proudfoot; S W Chan; K M O'Shaughnessy; P L Weissberg; C Vermeer; C M Shanahan Journal: J Biol Chem Date: 2001-06-25 Impact factor: 5.157
Authors: Ruben B Roijers; Nicola Debernardi; Jack P M Cleutjens; Leon J Schurgers; Peter H A Mutsaers; Ger J van der Vusse Journal: Am J Pathol Date: 2011-04-30 Impact factor: 4.307
Authors: S M Herrmann; C Whatling; E Brand; V Nicaud; J Gariepy; A Simon; A Evans; J B Ruidavets; D Arveiler; G Luc; L Tiret; A Henney; F Cambien Journal: Arterioscler Thromb Vasc Biol Date: 2000-11 Impact factor: 8.311
Authors: Patricia A Peyser; Lawrence F Bielak; Julia S Chu; Stephen T Turner; Darrell L Ellsworth; Eric Boerwinkle; Patrick F Sheedy Journal: Circulation Date: 2002-07-16 Impact factor: 29.690
Authors: Mei Y Speer; Marc D McKee; Robert E Guldberg; Lucy Liaw; Hsueh-Ying Yang; Elyse Tung; Gerard Karsenty; Cecilia M Giachelli Journal: J Exp Med Date: 2002-10-21 Impact factor: 14.307
Authors: Sagar U Nigwekar; Donald B Bloch; Rosalynn M Nazarian; Cees Vermeer; Sarah L Booth; Dihua Xu; Ravi I Thadhani; Rajeev Malhotra Journal: J Am Soc Nephrol Date: 2017-01-03 Impact factor: 10.121
Authors: Rajeev Malhotra; Christopher J Nicholson; Dongyu Wang; Vijeta Bhambhani; Samantha Paniagua; Charles Slocum; Haakon H Sigurslid; Christian L Lino Cardenas; Rebecca Li; Sophie L Boerboom; Yin-Ching Chen; Shih-Jen Hwang; Chen Yao; Fumito Ichinose; Donald B Bloch; Mark E Lindsay; Gregory D Lewis; Jayashri R Aragam; Udo Hoffmann; Gary F Mitchell; Naomi M Hamburg; Ramachandran S Vasan; Emelia J Benjamin; Martin G Larson; Warren M Zapol; Susan Cheng; Jason D Roh; Christopher J O'Donnell; Christopher Nguyen; Daniel Levy; Jennifer E Ho Journal: Arterioscler Thromb Vasc Biol Date: 2021-11-23 Impact factor: 8.311
Authors: D Tuñón-Le Poultel; J B Cannata-Andía; P Román-García; J B Díaz-López; E Coto; C Gómez; M Naves-Díaz; I Rodríguez Journal: Osteoporos Int Date: 2013-11-27 Impact factor: 4.507
Authors: Caitlin O'Rourke; Georgia Shelton; Joshua D Hutcheson; Megan F Burke; Trejeeve Martyn; Timothy E Thayer; Hannah R Shakartzi; Mary D Buswell; Robert E Tainsh; Binglan Yu; Aranya Bagchi; David K Rhee; Connie Wu; Matthias Derwall; Emmanuel S Buys; Paul B Yu; Kenneth D Bloch; Elena Aikawa; Donald B Bloch; Rajeev Malhotra Journal: J Vis Exp Date: 2016-05-31 Impact factor: 1.355
Authors: Rajeev Malhotra; Megan F Burke; Trejeeve Martyn; Hannah R Shakartzi; Timothy E Thayer; Caitlin O'Rourke; Pingcheng Li; Matthias Derwall; Ester Spagnolli; Starsha A Kolodziej; Konrad Hoeft; Claire Mayeur; Pawina Jiramongkolchai; Ravindra Kumar; Emmanuel S Buys; Paul B Yu; Kenneth D Bloch; Donald B Bloch Journal: PLoS One Date: 2015-01-20 Impact factor: 3.240